XML 74 R56.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF CONDENSED BALANCE SHEET (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets $ 189,651,000 $ 139,482,000
Total assets 388,971,000 312,164,000
Total liabilities 319,674,000 241,753,000
Total preferred stock and stockholders’ equity 69,652,000 70,766,000
Total liabilities and stockholders’ equity 388,971,000 312,164,000
Melt Pharmaceuticals, Inc. [Member]    
Current assets 3,068,000 13,404,000
Total assets 3,068,000 13,404,000
Total liabilities 3,008,000 3,922,000
Total preferred stock and stockholders’ equity 60,000 9,482,000
Total liabilities and stockholders’ equity $ 3,068,000 $ 13,404,000